GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 02/06/2010
PIL Varilrix

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/06/2010 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 03/03/2009 and displayed until 02/06/2010
Reasons for adding or updating:
  • Change to dosage and administration
  • Change to date of revision
  • Change to side-effects
Updated on 08/12/2008 and displayed until 03/03/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change due to user-testing of patient information
Updated on 17/08/2006 and displayed until 08/12/2008
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to storage instructions
  • Change to date of revision
Updated on 21/10/2004 and displayed until 17/08/2006
Reasons for adding or updating:
  • Change to drug interactions
  • Change to date of revision
Updated on 05/08/2002 and displayed until 21/10/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   varicella-zoster virus